About Erika M. Rosato, DNP, MHA, RN, OCN, NE-BC

Erika M. Rosato, DNP, MHA, RN, OCN, NE-BC Associate Chief Nurse for the Cancer Center, Obstetrics and Pediatrics.  Erika oversees the Cancer Center service line both inpatient and ambulatory and inpatient Obstetrics and Pediatrics.

Erika’s progressive career in oncology nursing has spanned 30 years including a variety of clinical and leadership roles at Massachusetts General Hospital, Spaulding Rehabilitation Program (across the Boston, Massachusetts Eye & Ear Infirmary, and Cambridge locations) and Lahey Clinic in Burlington. Erika has fostered collaboration and professional relationships across the interprofessional team with Boston, satellite and the network Cancer Center locations creating the opportunity for sharing best practices.  Erika has provided leadership support in standing up the Sickle Cell clinic geared towards bringing world class care to patients with sickle cell disease. She is a strong advocate for the Diversity, Inclusion and Equity agenda and is the co-founder of the Diversity and Inclusion Book Club which explores injustice and health inequity through discussions prompted by books, articles and relevant stories in the media. Since 2021, Erika has served as Faculty in co-teaching the Clinical Service Operations Skillsets course in the Masters in Clinical Service Operations Program at Harvard University.

Erika graduated from the University of Massachusetts, Lowell with both her Bachelors in Nursing and Masters in Health Administration. In 2019, she obtained her Doctorate in Nursing Science degree from Northeastern University.  Her doctoral work focused on clinical assessment of financial toxicity which she published in the Clinical Journal of Oncology Nursing. Erika is the recipient of numerous awards including in 2016 both the Massachusetts Governor’s and Senate Citations in Recognition of Dedicated Service and a One Hundred Award Recipient – an award that recognizes people who have uniquely and many times selflessly, dedicated themselves to lessening the tide of human suffering from cancer.